TITLE

Pharmacotherapeutic disparities: Racial, ethnic, and sex variations in medication treatment

AUTHOR(S)
Hall-Lipsy, Elizabeth A.; Chisholm-Burns, Marie A.
PUB. DATE
March 2010
SOURCE
American Journal of Health-System Pharmacy;3/15/2010, Vol. 67 Issue 6, p462
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Variations in the medication treatment received by racial and ethnic minorities and women and the negative health outcomes associated with these differences were examined. Methods. Studies published between January 1990 and June 2008 were identified via electronic searches of MEDLINE, PsychINFO, International Pharmaceutical Abstracts, PubMed, and CINAHL using search terms related to race, ethnicity, sex, drug treatment, and disparity or variation. Articles were excluded if they addressed only medical or surgical care or did not include a statistical analysis of differences in drug treatment based on race, ethnicity, or sex. Data regarding the frequency of reported race, ethnic, and sex differences in medication treatment, the types of treatment differences observed, and associated health outcomes were extracted. Results. A total of 311 research articles were identified that investigated whether race, ethnicity, or sex was associated with disparities in medication treatment. Seventyseven percent (n = 240) of included articles revealed significant disparities in drug treatment across race, ethnicity, and sex (p < 0.05). The most frequent disparity, found in 73% of the articles studied, was differences in the receipt of prescription drugs; however, documented disparities occurred related to differences in the drugs prescribed, drug dosing or administration, and wait time to receipt of a drug. Documented outcomes associated with pharmacotherapeutic disparities included increased rates of hospitalization, decreased rates of therapeutic goal attainment (e.g., lowdensity- lipoprotein cholesterol, blood pressure goals), and decreased rates of survival. Conclusion. A literature review revealed significant disparities in the medication treatment received by racial and ethnic minorities and women.
ACCESSION #
48478507

 

Related Articles

  • Gender Differences in Smoking and Self Reported Indicators of Health. Kirkland, Susan; Greaves, Lorraine; Devichand, Pratima // BMC Women's Health;2004 Supplement 1, Vol. 4, pS7 

    Health Issue: Smoking among Canadian women is a serious public health issue. Using the 1998-99 National Population Health Survey, this study examined underlying factors contributing to differences in prevalence of smoking among subgroups of women and men, and its effects on self-reported...

  • When the 'race and gender stuff' seems too hard. Coponi, Gena Dagel // Christian Science Monitor;12/8/97, Vol. 90 Issue 9, p15 

    Opinion. Looks at a conversation between a woman college assistant professor and college student who identifies with Anglo culture about classroom discussions on ethnicity and gender. His plan to go into human resources.

  • Gender Differences with Anticoagulation Discontinuation.  // Critical Care Alert;Oct2008 Pharmacology Watch, p1 

    The article discusses gender differences with discontinuation of anticoagulation after unprovoked venous thromboembolism.

  • Gender-specific research underway.  // Total Health;Mar/Apr97, Vol. 19 Issue 1, p12 

    Introduces the Partnership for Women's Health at Columbia University that will focus on a new concept called gender-specific medicine. Who introduced the initiative; Implication of the initiative.

  • Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. von Wagner, Christian; Baio, Gianluca; Raine, Rosalind; Snowball, Julia; Morris, Stephen; Atkin, Wendy; Obichere, Austin; Handley, Graham; Logan, Richard F; Rainbow, Sandra; Smith, Stephen; Halloran, Stephen; Wardle, Jane // International Journal of Epidemiology;Jun2011, Vol. 40 Issue 3, p712 

    Background: An organized, population-based, colorectal cancer screening programme was initiated in England in 2006 offering biennial faecal occult blood testing (FOBT) to adults aged 60-69 years. Organized screening programmes with no associated financial costs to the individual...

  • Pubertal development occurred earlier in girls vs. boys.  // Endocrine Today;Mar2010, Vol. 8 Issue 3, p25 

    The article reports on the finding that since differential secondary sex characteristics occur at different stages and times depending on sex and ethnicity, pubertal development may not be expressed solely with puberty onset and termination.

  • Ritalin: Mom's Little Helper. Ripley, Amanda // Time International (South Pacific Edition);2/12/2001, Issue 6, p57 

    Discusses the increase in the number of women who are getting treated with Ritalin for attention-deficit/hyperactivity disorder (ADHD). Assumption that they have had the condition since childhood and were overlooked; Concern that women are being overdiagnosed.

  • Ritalin: Mom's Little Helper. Ripley, Amanda // Time;2/12/2001, Vol. 157 Issue 6, p73 

    Discusses the increase in the number of women who are getting treated with Ritalin for attention-deficit/hyperactivity disorder (ADHD). Assumption that they have had the condition since childhood and were overlooked; Concern that women are being overdiagnosed.

  • What She Wants.  // Newsweek;Dec1999-Feb2000, Vol. 134, p86 

    Mentions the use of the potency drug Viagra in experiments to determine its effect on women. Expected results; Types of women who might benefit from the drug; Other drugs being tested to treat female sexual dysfunction.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics